title: The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up.
abstract: Whether renal transplant recipients with anti-HCV antibodies positivity and normal liver function tests within the first year after transplantation have different morbidity and mortality and graft failure compared to anti-HCV-negative recipients remains controversial. In this retrospective study, on 411 renal transplant recipients, we analyzed grafts morbidity, survival, and liver function tests over a period of 8 years. Patients were stratified according to their anti-HCV antibody status 1 year after transplantation into anti-HCV-positive and HCV-negative patients. The presence of normal liver function tests was mandatory at inclusion. All patients received the same immunosuppressive protocol consisting of cyclosporine A, mycophenolate mofetil and steroids. One year after transplantation, 137 patients were anti-HCV negative (33 %) while the rest 274 (67 %) were positive. At 5 years of follow-up, the study population consisted of 205 patients (71 patients, 35 % with anti-HCV negativity, and 134, 65 % with positivity). At the end of the study, only 144 patients were followed up (43 patients, 30 % with negative anti-HCV and 101 patients, 70 %, with positivity). We found that graft survival was not different between both groups. Moreover, serum creatinine showed a trend to be lower in HCV-positive patients compared to negative group although difference was not statistically significant. The number of graft loss was not different between both groups. Moreover, there was no difference between both groups as regards prevalence of acute rejection, diabetes mellitus, hypertension, CMV disease and proteinuria. We can conclude that anti-HCV positivity for 8 years in patients with normal liver function tests at 1 year does not impact graft morbidity and patient survival.
authors: Department of Nephrology, Cairo University, Cairo, Egypt, aroshdy@hotmail.com.
authors: A R
authors: AR
authors: Soliman
authors: A
authors: A
authors: Fathy
authors: S
authors: S
authors: Khashab
authors: N
authors: N
authors: Shaheen
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006085:Graft Survival; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000150:complications; D006801:Humans; D007668:Kidney / Q000502:physiology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D003404:Creatinine
references: ISRN Nephrol. 2012 Oct 31;2013:395467
references: 24967226
references: J Gen Virol. 1993 Nov;74 ( Pt 11):2391-9
references: 8245854
references: Nephrol Dial Transplant. 2002 Jan;17(1):129-33
references: 11773476
references: Am J Transplant. 2005 Jun;5(6):1452-61
references: 15888054
references: Transplantation. 1998 Apr 15;65(7):930-6
references: 9565097
references: Biochem Biophys Res Commun. 2004 Jan 2;313(1):42-7
references: 14672695
references: Kidney Int. 1998 May;53(5):1374-81
references: 9573555
references: Am J Transplant. 2007 Sep;7(9):2124-32
references: 17608832
references: Transplantation. 1998 Mar 15;65(5):667-70
references: 9521201
references: Am J Kidney Dis. 2003 Jul;42(1):193-201
references: 12830472
references: Arch Virol. 1998;143(12):2493-503
references: 9930205
references: Curr Opin Nephrol Hypertens. 1998 Mar;7(2):177-83
references: 9529620
references: NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46
references: 14768714
references: Hepatology. 2000 Jul;32(1):111-5
references: 10869297
references: N Engl J Med. 1995 Jun 1;332(22):1463-6
references: 7739682
references: Kidney Int. 1997 Sep;52(3):843-61
references: 9291208
references: Hepatology. 1997 Sep;26(3 Suppl 1):21S-28S
references: 9305659
references: Nephrol Dial Transplant. 2004 Jun;19 Suppl 3:iii72-6
references: 15192141
references: Hepatology. 2003 Nov;38(5):1282-8
references: 14578868
references: Nephrol Dial Transplant. 2001 Aug;16(8):1545-9
references: 11477152
references: Semin Nephrol. 2002 Jul;22(4):365-74
references: 12118402
references: J Egypt Public Health Assoc. 1995;70(5-6):465-84
references: 17214170
references: Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S97-S101
references: 16234071
references: J Mol Evol. 2004 Feb;58(2):191-5
references: 15042339
references: Lancet. 2000 Mar 11;355(9207):887-91
references: 10752705
references: Transplantation. 2004 Sep 15;78(5):745-50
references: 15371680
references: Hepatology. 1990 Oct;12(4 Pt 1):671-5
references: 2170265
references: Mol Biol Evol. 2003 Mar;20(3):381-7
references: 12644558
references: J Gastroenterol. 2003;38(6):567-72
references: 12825133
references: Antivir Ther. 2005;10(1):1-11
references: 15751759
references: J Hepatol. 1997 Feb;26(2):236-43
references: 9059941